The impact of early de novo donor-specific antibodies on lung transplant outcomes: Is timing everything?

被引：1
|
作者：
King, Christopher S. [1 ]
Cochrane, Adam B. [2 ]
机构：
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant Clin, 618 S Royal St, Falls Church, VA 22314 USA
[2] Inova Fairfax Hosp, Adv Lung Dis Clin, Dept Pharm, Falls Church, VA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2016年 / 35卷 / 09期
关键词：
BRONCHIOLITIS OBLITERANS SYNDROME; MEDIATED REJECTION; INTERNATIONAL SOCIETY; HLA-ANTIBODIES; HEART;
D O I：
10.1016/j.healun.2016.07.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1057 / 1058
页数：2
相关论文
共 50 条
  • [41] The Impact of De Novo Donor-Specific Antibodies on Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome
    Miyamoto, E.
    Martinu, T.
    Klement, W.
    Juvet, S.
    Keshavjee, S.
    Tinckam, K.
    Tikkanen, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S34 - S34
  • [42] Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death
    Keller, Michael
    Yang, Song
    Ponor, Lucia
    Bon, Ann
    Cochrane, Adam
    Philogene, Mary
    Bush, Errol
    Shah, Pali
    Mathew, Joby
    Brown, Anne W.
    Kong, Hyesik
    Charya, Ananth
    Luikart, Helen
    Nathan, Steven D.
    Khush, Kiran K.
    Jang, Moon
    Agbor-Enoh, Sean
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (04) : 559 - 564
  • [43] Impact of Primary Disease Nature in the Development of De Novo Donor-Specific Antibodies After Kidney Transplant and the Risk of Acute Rejection
    Lionaki, Sophia
    Pappas, Apostolos
    Altanis, Nikolaos
    Kapsia, Helen
    Liapis, George
    Vittoraki, Angeliki
    Iniotaki, Alice
    Zavos, George
    Boletis, John N.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 (03) : 304 - 312
  • [44] Utility of Protocol Pancreas Biopsies for De Novo Donor-specific Antibodies
    Parajuli, Sandesh
    Mandelbrot, Didier
    Odorico, Jon
    TRANSPLANTATION DIRECT, 2022, 8 (03):
  • [45] Prevalence and Risk Factors for De Novo HLA Donor-Specific Antibodies in Adult Heart Transplant Recipients
    Goldraich, L. A.
    Alba, A. C.
    Ross, H. J.
    Tinckam, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S291 - S292
  • [46] Below the WaterlineuThe Danger of De Novo Donor-Specific HLA Antibodies
    Kokko, K. E.
    Colvin, R. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1077 - 1078
  • [47] Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients
    Jucaud, Vadim
    Shaked, Abraham
    DesMarais, Michele
    Sayre, Peter
    Feng, Sandy
    Levitsky, Josh
    Everly, Matthew J.
    HEPATOLOGY, 2019, 69 (03) : 1273 - 1286
  • [48] De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation
    Tikkanen, Jussi M.
    Singer, Lianne G.
    Kim, S. Joseph
    Li, Yanhong
    Binnie, Matthew
    Chaparro, Cecilia
    Chow, Chung-Wai
    Martinu, Tereza
    Azad, Sassan
    Keshavjee, Shaf
    Tinckam, Kathryn
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (05) : 596 - 606
  • [49] De Novo Donor-Specific Antibody Development with Mycophenolate versus Azathioprine in Lung Transplant Recipients.
    Prom, A.
    Walter, K.
    Gomez, K.
    Doligalski, C.
    Lobo, L.
    Evans, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 481 - 482
  • [50] Impact of de novo donor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation
    Malheiro, Jorge
    Martins, La Salete
    Tafulo, Sandra
    Dias, Leonidio
    Fonseca, Isabel
    Beirao, Idalina
    Castro-Henriques, Antonio
    Cabrita, Antonio
    TRANSPLANT INTERNATIONAL, 2016, 29 (02) : 173 - 183
12345